ODDB.org: Open Drug Database

Sandoz Pharmaceuticals AG - Rixathon 500 mg/50 ml, Konzentrat zur Herstellung einer Infusionslösung

Swissmedic Registration	66435	Sequence	02
Product name	Rixathon 500 mg/50 ml	Description	Konzentrat zur Herstellung einer Infusionslösung
ATC-Classification	L01FA01	ATC-Description	Rituximab
Introduction of Sequence	03.07.2018

Composition

rituximabum 500 mg, acidum citricum monohydricum, natrii chloridum, polysorbatum 80, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 50 ml corresp. natrium 177.03 mg.

Packungsbestandteile

Galenic Form

Concentrate for infusion

Excipiens

Active Agent	Dose
Rituximab	500mg / 50ml

BAG: Active Agent	Dose
Rituximab	500 mg

Inactive agents
Citric Acid Monohydrate
Acidum Hydrochloridum ad Ph
Sodium Chloride
Natrii Hydroxidum ad Ph
Polysorbatum 80

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
003		1051.32	1159.80	A	SL	No
004	2			A		Yes

2026	©ywesee GmbH